Shareholder Information

Prev Next

All enquiries concerning your shareholding should be directed to the Company's Registrar, Link Asset Services.

During this challenging time, extra pressure is being put on telephone services.

Therefore, to help those shareholders who need it the most, please can we encourage you to make use of the online Share Portal.

To access your shareholding via the Share Portal click here.

Admission to AIM
from 7 November 2018 as YGEN - from 4 July 2014 to 6 November 2018 as NIPT
AIM symbol
YGEN (formerly NIPT)
ISIN Number
Number of shares in issue
3,176,959,692 (Date last updated 17 January 2023)
% of shares not in public hands
27.3% (Date last updated 17 January 2023)
Significant Shareholders with more than 3%:
(Date last updated 17 January 2023)
- Dr Bill Chang and Changsform Innovations Pte. Ltd
- Mr Steven Myers
- Spreadex

The company is listed on the AIM market of the London Stock Exchange, and is subject to the UK City Code on Takeovers and Mergers.

Dr Bill Chang (a Company director and beneficial owner of Changsform Innovations Pte Ltd) holds options over 300,000 new ordinary shares, exercisable at 10.0p, and options over 400,000 new ordinary shares, exercisable at 7.75p, and options over 400,000 new ordinary shares, exercisable at 10.25p. There are no other options, warrants or any other instruments held by significant shareholders.

Life Technologies Limited holds warrants over 20,325,204 new ordinary shares exercisable at 24.6p, warrants over 17,094,018 new ordinary shares exercisable at 11.7p, and warrants over 16,913,319 new ordinary shares exercisable at 11.8p.

Subsequent to the acquisition of Coastal Genomics, Inc (now renamed Yourgene Health Canada Ltd) completed on 7 August 2020, certain of the former shareholders in that company were issued 10,249,624 new shares in Yourgene Health Canada Investments Ltd (YHCIL), a subsidiary of Yourgene Health plc, incorporated under the laws of British Columbia, Canada. These shares do not carry voting rights, but entitle the holders thereof to participate in any Group dividends on an equivalent basis and are capable of being exchanged for Ordinary Shares in the Company at a price of 18.3 pence per Ordinary Share, subject to lock-in restrictions until 31 March 2023. In April 2021 a further 4,696,065 such YHCIL shares were issued, exchangeable at 14.8 pence. In August 2021 a further 4,880,971 YHCIL shares were issued, exchangeable at 14.3 pence.  On 27 January 2022 3,319,937 YHCIL shares were exchanged for shares in Yourgene Health plc leaving a further 16,506,723 YHCIL shares available for exchange into Yourgene Health plc subject to the remaining lock-in conditions.

Donate your shares to charity

If you have only a small number of shares which are uneconomical to sell you may wish to donate them to charity free of charge through ShareGift (Registered Charity10528686). Find out more at or by telephoning 020 7930 3737.

Follow this link for Share Price Graph

Warning to Shareholders

It has come to our attention that recently a small number of shareholders have received unsolicited telephone calls concerning their investments in Yourgene Health plc. Such calls have related to offers to potentially purchase shares for considerably more than the current market price, further details of which would be disclosed once the shareholders concerned signed a non-disclosure agreement.

Shareholders should be wary of any unsolicited advice. Following a recent increase in the prevalence of so called “boiler room” scams, the Financial Services Authority (FSA) and the Institute of Chartered Secretaries (ICSA) have produced a leaflet warning investors about unsolicited communications concerning investment matters which is available in full by clicking on the link below.


• Make sure you get the correct name of the person and organisation
• Check that they are properly authorised by the FSA before getting involved by visiting
• Report the matter to the FCA either by calling 0800 111 6768 or visiting
• If the calls persist hang up.

If you have any queries please contact our Company Secretary on 01620 810183.

Pen and Paper